|
sessions |
LECTURES COMMUNICATIONS |
THE EXPERTS |
| Symposium Organon: NuvaRing. Not your everyday contraceptive | |
| Symposium Leiras: The Mirena levonorgestrel system: freedom of choice in long-acting contraception | |
| Symposium Schering (Yasmin): Added value in oral contraception:the unique properties of Yasmin | |
| Symposium Wyeth | |
| Abstracts | Meet
the experts |
 |
° Long acting
methods of contraception |
| D.Mansour (United
Kingdom) and G.Bartfai (Hungary) |
|
|
° Spermicides |
| P.F.A.van Look
(WHO) and M.Lech (Poland) |
|
| WHO-report |
|
| Abstracts | Symposium Organon:
NuvaRing. Not your everyday contraceptive |
| Chairman: I.
Milsom (Sweden) |
|
| Co-chairman: M
Vree (The Netherlands) |
|
|
° Complete and
robust ovulation inhibition with NuvaRing |
| S. Killick United
Kingdom) |
|
|
° High
contraceptive efficacy and tolerability with NuvaRing |
| F. Roumen (The
Netherlands) |
|
|
° Lower hormone
dosage with improved cycle control |
| M. Vree (The
Netherlands) |
|
|
° High
acceptability and satisfaction with NuvaRing use |
| A. Szarewski (United
Kingdom) |
|
|
|
|
| Abstracts | Symposium
Leiras: The Mirena levonorgestrel system: freedom of choice in long-acting contraception |
| Chairman: A.
Glasier (United Kingdom) |
|
| ° Introduction
to long-acting contraceptive methods |
|
| A. Glasier (United
Kingdom) |
|
| ° The Mirena
levonorgestrel system: the German experience |
|
| H.A. von
Waldenfels (Germany) |
|
| °
The Mirena levonorgestrel system: effective contraception with health benefits |
|
| A. Evans (United
Kingdom) |
